Clinical Utility of Monoclonal Gammopathy Testing in the Evaluation of Anemia
American Journal of Hematology · 2026
DOI: 10.1002/ajh.70102 ↗Kurz gefasst
Leserbrief in der Zeitschrift American Journal of Hematology, 2026. Verfasst von Mackenzie D Maberry und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Anemia, Paraproteinemias. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
- Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
ORCID-Profile: Mackenzie D Maberry, Caleb J Smith, Ronald S Go
Zitieren
APA
Maberry, M. D., Smith, C. J., & Go, R. S. (2026). Clinical Utility of Monoclonal Gammopathy Testing in the Evaluation of Anemia. American Journal of Hematology. https://doi.org/10.1002/ajh.70102
Vancouver
Maberry MD, Smith CJ, Go RS. Clinical Utility of Monoclonal Gammopathy Testing in the Evaluation of Anemia. American Journal of Hematology. 2026. doi:10.1002/ajh.70102
BibTeX
@article{Maberry2026,
author = {Maberry, Mackenzie D and Smith, Caleb J and Go, Ronald S},
title = {Clinical Utility of Monoclonal Gammopathy Testing in the Evaluation of Anemia},
journal = {American Journal of Hematology},
year = {2026},
doi = {10.1002/ajh.70102}
}
EUVIMED